The growth of this market is mainly driven by increasing research activity on glycomics, increasing R&D investment in pharmaceutical and biotechnology companies, and growth of the proteomics market.
[173 Pages Report] The global glycomics market is estimated to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a CAGR of 13.8%.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525
Report Scope and Market Segmentation:
| Report Metric | Details |
| Market Size Available for Years | 2019–2026 |
| Base Year Considered | 2020 |
| Forecast Period | 2022–2026 |
| Forecast Units | Value (USD Billion) |
| Segments Covered | Product, application, end-user, and region |
| Geographies Covered | North America, Europe, APAC, LATAM, and MEA |
| Companies Covered | Merck KGaA (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), New England Biolabs (US), Shimadzu Corporation (Japan), Takara Bio (Japan), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters Corporation (US), Asparia Glycomics S.L. (Spain), Bio-Techne (US), Bruker Corporation (US), Danaher Corporation (US), RayBiotech (US), Z Biotech (US), Chemily Glycoscience (US), Dextra Laboratories (UK), Lectenz Bio (US), and Ludger Ltd. (UK). |
The enzymes segment accounted for the largest share of the glycomics market, by product
The glycomics market, by enzymes, has been categorized into five product segments, namely, enzymes, instruments, kits, carbohydrates, and reagents & chemicals. The enzymes segment is expected to dominate the market in 2020 and is projected to grow at the highest CAGR during the forecast period.
Glycomics market for drug discovery & development application is expected to grow at a high rate
By application, the glycomics market is segmented into drug discovery & development, disease diagnostics, and other applications. Drug discovery & development is the largest and the fastest-growing application segment in the glycomics market, majorly due to the increasing R&D investments in pharmaceutical and biotechnology companies and the growing number of drug discovery research activities in academic research institutes.
North America is the largest regional market for glycomics products
The global glycomics market is segmented into North America (US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, and the Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa).
Merck KGaA the leading player in the glycomics market, with the largest share in market. In the glycomics market, the company offers various products, including kits, enzymes, carbohydrates, and reagents & chemicals. Substantial business operations across all key regions, coupled with a strong brand image, make the company a leading player in this market.
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525
